DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
SCY-078 is an investigational drug.
There have been 13 clinical trials for SCY-078. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2017.
The most common disease conditions in clinical trials are Candidiasis, Candidiasis, Vulvovaginal, and Mycoses. The leading clinical trial sponsors are Scynexis, Inc., Clinical Network Services (CNS) Pty Ltd, and Inncelerex.
There are two US patents protecting this investigational drug and fourteen international patents.
Recent Clinical Trials for SCY-078
|ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects||Inncelerex||Phase 1|
|ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects||Scynexis, Inc.||Phase 1|
|Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy Subjects||Clinical Network Services (CNS) Pty Ltd||Phase 1|
Top disease conditions for SCY-078
Top clinical trial sponsors for SCY-078
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|SCY-078||Try Before You Buy||Salts and polymorphs of SCY-078||SCYNEXIS, INC. (Jersey City, NJ)||Try Before You Buy|
|SCY-078||Try Before You Buy||Antifungal agents||Merck Sharp & Dohme Corp. (Rahway, NC) Seynexis, Inc. (Research Triangle Park, NC)||Try Before You Buy|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|SCY-078||Eurasian Patent Organization||EA036874||2035-01-19||Try Before You Buy|
|SCY-078||Eurasian Patent Organization||EA201791645||2035-01-19||Try Before You Buy|
|SCY-078||European Patent Office||EP3247711||2035-01-19||Try Before You Buy|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|